“Study leveraged EHRs from two health systems, over 1,400 patients and was believed to be one of the first PMA label expansions based solely on EHR data”

FDA Watch · The Rise of Real-World Evidence in Regulatory Strategy, Part 2: RWE in Medical Devices

Play from 13:42
13:42

Audio streams from the publisher’s own feed. Verbatim does not host or copy it.

What was described

ran a pre-market regulatory submission for a thermal ablation catheter using EHR data from two health systems covering over 1,400 patients

1,400 patients

Said nearby on the same subject

“Submission... restarted using a retrospective EHR and lab data set... provided longitudinal follow-up of about three years and resulted in a successful approval”
♫
Said on FDA Watch
How they work 3 years longitudinal follow-up Share this moment
“They're using de-identified patient data, we're going to be tracking to see whether doing these whole body MRIs actually improve health outcomes down the line”
♫
Said on The Readout Loud
Data play Share this moment
“We just signed our 31st health system. We're in 13 states and two countries... white-labeled... gives these health systems the same sort of tech-enabled logistics experience.”
♫
Said on Pharmacy Podcast Network
Business model 31 health systems; 13 states; 2 countries Share this moment
“We have a system where we have two SMEs right now, including myself. We stay on top of this to make sure that all of our regulatory requirements are aligned with what's present.”
NC
Nick Coleman
Lawyerist Podcast ·
How they work Share this moment

Moments like this, every Monday

The strongest new moments on your topics, in the speakers' own words. Free for three topics.

No card. No password. One-click unsubscribe.

Track a competitor?

Pro watches up to 25 names or phrases and emails you the morning after they are said.

See Pro, $29 a month

Verbatim quotes a short extract and links to the episode; the episode belongs to its publisher. Remove a show.